These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 11353623)

  • 1. Multidrug efflux pumps: expression patterns and contribution to antibiotic resistance in Pseudomonas aeruginosa biofilms.
    De Kievit TR; Parkins MD; Gillis RJ; Srikumar R; Ceri H; Poole K; Iglewski BH; Storey DG
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1761-70. PubMed ID: 11353623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the MexA-MexB-oprM multidrug efflux system on expression of the MexC-MexD-oprJ and MexE-MexF-oprN multidrug efflux systems in Pseudomonas aeruginosa.
    Li XZ; Barré N; Poole K
    J Antimicrob Chemother; 2000 Dec; 46(6):885-93. PubMed ID: 11102405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of azithromycin-resistant Pseudomonas aeruginosa biofilms.
    Gillis RJ; White KG; Choi KH; Wagner VE; Schweizer HP; Iglewski BH
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3858-67. PubMed ID: 16127063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of the multidrug efflux pumps MexCD-OprJ and MexEF-OprN is associated with a reduction of type III secretion in Pseudomonas aeruginosa.
    Linares JF; López JA; Camafeita E; Albar JP; Rojo F; Martínez JL
    J Bacteriol; 2005 Feb; 187(4):1384-91. PubMed ID: 15687203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Pseudomonas aeruginosa multidrug efflux pumps MexA-MexB-OprM and MexC-MexD-OprJ in a multidrug-sensitive Escherichia coli strain.
    Srikumar R; Kon T; Gotoh N; Poole K
    Antimicrob Agents Chemother; 1998 Jan; 42(1):65-71. PubMed ID: 9449262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A combined phenotypic and genotypic method for the detection of Mex efflux pumps in Pseudomonas aeruginosa.
    Mesaros N; Glupczynski Y; Avrain L; Caceres NE; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2007 Mar; 59(3):378-86. PubMed ID: 17289770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of carbapenem and multidrug resistance with the expression of efflux pump-encoding genes in Pseudomonas aeruginosa clinical isolates.
    Yousefi S; Nazari M; Ramazanzadeh R; Sahebkar A; Safarzadeh E; Khademi F
    Acta Microbiol Immunol Hung; 2023 Jun; 70(2):161-166. PubMed ID: 37227802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional Analysis of MexAB-OprM Efflux Pumps System of Pseudomonas aeruginosa and Its Role in Carbapenem Resistance in a Tertiary Referral Hospital in India.
    Choudhury D; Das Talukdar A; Dutta Choudhury M; Maurya AP; Paul D; Dhar Chanda D; Chakravorty A; Bhattacharjee A
    PLoS One; 2015; 10(7):e0133842. PubMed ID: 26221722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ.
    Chuanchuen R; Beinlich K; Hoang TT; Becher A; Karkhoff-Schweizer RR; Schweizer HP
    Antimicrob Agents Chemother; 2001 Feb; 45(2):428-32. PubMed ID: 11158736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of a series of mutants lacking all of the four major mex operons for multidrug efflux pumps or possessing each one of the operons from Pseudomonas aeruginosa PAO1: MexCD-OprJ is an inducible pump.
    Morita Y; Komori Y; Mima T; Kuroda T; Mizushima T; Tsuchiya T
    FEMS Microbiol Lett; 2001 Aug; 202(1):139-43. PubMed ID: 11506922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MerR-like regulator BrlR confers biofilm tolerance by activating multidrug efflux pumps in Pseudomonas aeruginosa biofilms.
    Liao J; Schurr MJ; Sauer K
    J Bacteriol; 2013 Aug; 195(15):3352-63. PubMed ID: 23687276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of RND efflux pumps mediated antibiotic resistance in Pseudomonas aeruginosa clinical strains.
    Zahedi Bialvaei A; Rahbar M; Hamidi-Farahani R; Asgari A; Esmailkhani A; Mardani Dashti Y; Soleiman-Meigooni S
    Microb Pathog; 2021 Apr; 153():104789. PubMed ID: 33556480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy.
    Lomovskaya O; Warren MS; Lee A; Galazzo J; Fronko R; Lee M; Blais J; Cho D; Chamberland S; Renau T; Leger R; Hecker S; Watkins W; Hoshino K; Ishida H; Lee VJ
    Antimicrob Agents Chemother; 2001 Jan; 45(1):105-16. PubMed ID: 11120952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inner membrane efflux components are responsible for beta-lactam specificity of multidrug efflux pumps in Pseudomonas aeruginosa.
    Srikumar R; Li XZ; Poole K
    J Bacteriol; 1997 Dec; 179(24):7875-81. PubMed ID: 9401051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1.
    Dean CR; Visalli MA; Projan SJ; Sum PE; Bradford PA
    Antimicrob Agents Chemother; 2003 Mar; 47(3):972-8. PubMed ID: 12604529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assignment of the substrate-selective subunits of the MexEF-OprN multidrug efflux pump of Pseudomonas aeruginosa.
    Maseda H; Yoneyama H; Nakae T
    Antimicrob Agents Chemother; 2000 Mar; 44(3):658-64. PubMed ID: 10681335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structures of OprN and OprJ, outer membrane factors of multidrug tripartite efflux pumps of Pseudomonas aeruginosa.
    Yonehara R; Yamashita E; Nakagawa A
    Proteins; 2016 Jun; 84(6):759-69. PubMed ID: 26914226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced efficacy of putative efflux pump inhibitor/antibiotic combination treatments versus MDR strains of Pseudomonas aeruginosa in a Galleria mellonella in vivo infection model.
    Adamson DH; Krikstopaityte V; Coote PJ
    J Antimicrob Chemother; 2015 Aug; 70(8):2271-8. PubMed ID: 25921513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic Compensation of Fitness Costs Is a General Outcome for Antibiotic-Resistant
    Olivares Pacheco J; Alvarez-Ortega C; Alcalde Rico M; Martínez JL
    mBio; 2017 Jul; 8(4):. PubMed ID: 28743808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms.
    Poole K
    J Mol Microbiol Biotechnol; 2001 Apr; 3(2):255-64. PubMed ID: 11321581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.